Ocera Therapeutics, Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d7896e29-a93d-4aed-82ae-549989bc3a07/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $609.0k | 2016-01-01 – 2016-12-31 | evidence 0001274644-17-000014 |
| FY 2015 | $133.0k | 2015-01-01 – 2015-12-31 | evidence 0001274644-17-000014 |
| FY 2014 | $341.0k | 2014-01-01 – 2014-12-31 | evidence 0001274644-17-000014 |
| FY 2013 | $130.0k | 2004-12-20 – 2014-03-31 | evidence 0001274644-14-000009 |
| FY 2012 | $0 | 2012-01-01 – 2012-12-31 | evidence 0001274644-14-000004 |
| FY 2011 | $10.2M | 2011-01-01 – 2011-12-31 | evidence 0001274644-12-000007 |
| FY 2010 | $8.5M | 2010-01-01 – 2010-12-31 | evidence 0001274644-12-000007 |
| FY 2009 | $728.0k | 2009-01-01 – 2009-12-31 | evidence 0001274644-12-000007 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Ocera Therapeutics, Inc. — all facts · Net Income · Operating Income